Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$425K Sell
1,173
-60
-5% -$20.5K 0.09% 109
2026
Q1
$434K Buy
1,233
+4
+0.3% +$1.43K 0.11% 97
2025
Q4
$402K Sell
1,229
-12
-1% -$3.81K 0.1% 102
2025
Q3
$350K Buy
1,241
+5
+0.4% +$1.45K 0.1% 104
2025
Q2
$345K Buy
1,236
+5
+0.4% +$1.42K 0.11% 98
2025
Q1
$383K Buy
1,231
+4
+0.3% +$1.18K 0.13% 87
2024
Q4
$320K Buy
+1,227
New +$364K 0.11% 90

Other funds holding AMGN

CLG LLC's AMGN Position: Q2 2026 in Review

CLG LLC reduced its Amgen (AMGN) stake by 4.9% in Q2 2026, selling an estimated $20.5K and leaving 1,173 shares worth $425K. The position accounts for 0.09% of the portfolio, ranked #109.

CLG LLC first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $434K in Q1 2026. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • CLG LLC held 1,173 shares of Amgen worth $425K as of Q2 2026.
  • CLG LLC sold 60 Amgen shares in Q2 2026, an estimated $20.5K.
  • Amgen made up 0.09% of CLG LLC's portfolio in Q2 2026, its #109 holding.
  • CLG LLC first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • CLG LLC's Amgen position peaked at $434K in Q1 2026.
  • 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on CLG LLC's 13F filing for Q2 2026, filed 16 Jul 2026.